Biology of Hodgkin's lymphoma

被引:102
作者
Küppers, R
Schwering, I
Bräuninger, A
Rajewsky, K
Hansmann, ML
机构
[1] Univ Cologne, Dept Internal Med 1, D-50931 Cologne, Germany
[2] Univ Cologne, Inst Genet, D-50931 Cologne, Germany
[3] Goethe Univ Frankfurt, Dept Pathol, D-6000 Frankfurt, Germany
关键词
angioimmunoblastic lymphadenopathy; cell fusion; composite lymphoma; Hodgkin's lymphoma; Reed-Sternberg cell; somatic hypermutation;
D O I
10.1093/annonc/13.S1.11
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Significant progress has been made in recent years in our understanding of the cellular origin of Hodgkin and Reed-Sternberg (HRS) cells in Hodgkin's lymphoma (HL). It is now clear that in most instances HRS cells represent clonal populations of transformed germinal centre (GC) B cells. While the tumour cells in the lymphocyte predominant type of the disease resemble mutating and antigen-selected GC B cells, there is evidence that HRS cells in classical HL originate from pro-apoptotic GC B cells. HRS cells of the recently defined novel subtype lymphocyte-rich classical HL moleculary resemble HRS cells of the other types of classical HL, but there appear to be phenotypic differences. In rare cases, HRS cells derive from T cells. In contrast to previous speculations, cell fusion apparently does riot play a role in the generation of the tumour clone. By gene expression profiling of HL cell lines, it became evident that HRS cells have lost most of the B cell-typical gene expression program, which may explain why these cells can persist without B cell receptor expression and which suggests that at least one of the transforming events involved in HL pathogenesis affects a master regulator of cell lineage identity.
引用
收藏
页码:11 / 18
页数:8
相关论文
共 64 条
[1]  
ABELEV GI, 1999, BIOCHEMISTRY-US, V65, P127
[2]  
Anagnostopoulos I, 2000, BLOOD, V96, P1889
[3]  
ANDREESEN R, 1989, NEW ENGL J MED, V321, P543
[4]   Constitutive nuclear factor-κB-RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells [J].
Bargou, RC ;
Emmerich, F ;
Krappmann, D ;
Bommert, K ;
Mapara, MY ;
Arnold, W ;
Royer, HD ;
Grinstein, E ;
Greiner, A ;
Scheidereit, C ;
Dörken, B .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (12) :2961-2969
[5]   Hodgkin and Reed-Sternberg cells in lymphocyte predominant Hodgkin disease, represent clonal populations of germinal center-derived tumor B cells [J].
Braeuninger, A ;
Kuppers, R ;
Strickler, JG ;
Wacker, HH ;
Rajewsky, K ;
Hansmann, ML .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (17) :9337-9342
[6]   Identification of common germinal-center B-cell precursors in two patients with both Hodgkin's disease and non-Hodgkin's lymphoma [J].
Bräuninger, A ;
Hansmann, ML ;
Strickler, JG ;
Dummer, R ;
Burg, G ;
Rajewsky, K ;
Küppers, R .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (16) :1239-1247
[7]   Survival and clonal expansion of mutating "forbidden" (immunoglobulin receptor-deficient) Epstein-Barr virus-infected B cells in angioimmunoblastic T cell lymphoma [J].
Bräuninger, A ;
Spieker, T ;
Willenbrock, K ;
Gaulard, P ;
Wacker, HH ;
Rajewsky, K ;
Hansmann, ML ;
Küppers, R .
JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 194 (07) :927-940
[8]   HODGKINS-DISEASE - THE STERNBERG-REED CELL [J].
BUCSKY, P .
BLUT, 1987, 55 (05) :413-420
[9]   Mutations in the IkBa gene in Hodgkin's disease suggest a tumour suppressor role for IκBα [J].
Cabannes, E ;
Khan, G ;
Aillet, F ;
Jarrett, RF ;
Hay, RT .
ONCOGENE, 1999, 18 (20) :3063-3070
[10]  
Chan WC, 2001, HEMATOL ONCOL, V19, P1